Balaji Amines Performance degli utili passati
Criteri Il passato verificati 4/6
Gli utili di Balaji Amines sono diminuiti a un tasso medio annuo di -19.9%, mentre il settore Chemicals ha visto gli utili crescere a un tasso medio annuo di 5.5%. I ricavi sono cresciuti diminuire a un tasso medio annuo di 10.5%. Il ritorno sul capitale proprio di Balaji Amines è 9.8% e ha margini netti di 13.4%.
Informazioni chiave
-19.91%
Tasso di crescita degli utili
-19.91%
Tasso di crescita dell'EPS
| Chemicals Crescita del settore | 17.68% |
| Tasso di crescita dei ricavi | -10.49% |
| Rendimento del capitale proprio | 9.79% |
| Margine netto | 13.41% |
| Ultimo aggiornamento sugli utili | 30 Jun 2026 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Aggiornamento narrativa • Jul 23
530999: Rich Future P/E Expectations Will Likely Limit Share Price Upside
The analyst price target for Balaji Amines has shifted from ₹1,447.50 to ₹2,085.67. Analysts point to updated assumptions around revenue growth, profit margins, discount rate and future P/E expectations to support this change.
Aggiornamento narrativa • Jul 09
530999: Higher Future P E Will Support Returns Despite Slight Margin Pressure
Analysts have raised their fair value estimate for Balaji Amines from ₹1,494 to ₹3,327, citing revised assumptions on the discount rate, revenue growth, profit margin and forward P/E as the key drivers of the updated price target. What’s in the News for Balaji Amines Balaji Amines has scheduled a Board Meeting on May 13, 2026.Aggiornamento narrativa • Jun 18
530999: Higher P E And Weaker Margins Will Pressure Future Returns
Analysts have raised their price target on Balaji Amines to ₹1,494 from ₹1,334, reflecting updated assumptions for revenue growth, profit margins and future P/E expectations. What’s in the News for Balaji Amines Balaji Amines has scheduled a board meeting for May 13, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.Aggiornamento narrativa • May 21
530999: Lower Multiple Expectations Will Drive Cautious View Despite Margin Optimism
Analysts have trimmed their fair value estimate for Balaji Amines from ₹1,561 to ₹1,334, citing updated assumptions around revenue growth, profit margins and future P/E expectations. What's in the News Board meeting scheduled for May 13, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 (Key Developments) Board to consider recommending a final dividend on equity shares for the financial year ended March 31, 2026, subject to shareholder approval at the 38th Annual General Meeting (Key Developments) Matters related to the upcoming 38th Annual General Meeting, including formal approvals and shareholder items, are also on the board meeting agenda (Key Developments) Valuation Changes Fair Value: Trimmed from ₹1,561 to ₹1,334, indicating a lower central estimate for the stock's worth based on updated assumptions.
Aggiornamento narrativa • May 07
530999: Higher Assumed Margins And P E Multiple Will Likely Limit Upside
Analysts have maintained their price target for Balaji Amines at ₹1,334. This reflects updated views based on a slightly lower discount rate, a modestly higher assumed revenue growth of 21.69% and a profit margin of 14.49%, as well as a revised future P/E assumption of 18.64x.Aggiornamento narrativa • Apr 23
530999: Higher Revenue Outlook And Lean Margins Will Support Future Upside
Analysts have trimmed their price target for Balaji Amines from ₹1,616.67 to ₹1,447.50, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E. Valuation Changes Fair Value: Trimmed from ₹1,616.67 to ₹1,447.50, indicating a lower central estimate for the share price.Aggiornamento narrativa • Apr 08
530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing
Analysts have kept the price target for Balaji Amines steady at ₹1,561, citing slightly adjusted assumptions on the discount rate, revenue growth, profit margin and forward P/E as the main factors behind the unchanged view. What's in the News A board meeting is scheduled for January 29, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Key Developments).Aggiornamento narrativa • Mar 24
530999: Refined Margins And P E Assumptions Will Likely Support Returns
Analysts have maintained their fair value estimate for Balaji Amines at ₹1,334. The steady price target is supported by only small adjustments to the discount rate, revenue growth assumptions, profit margin and future P/E expectations.Aggiornamento narrativa • Mar 10
530999: Refined Margins And P E Assumptions Will Likely Support Returns
Analysts have kept their fair value estimate for Balaji Amines steady at ₹1,334, with small refinements to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. What's in the News A board meeting is scheduled on Jan 29, 2026 to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).Aggiornamento narrativa • Feb 23
530999: Higher Future P E And Margins Will Likely Support Returns
Analysts have maintained their price target for Balaji Amines at ₹1,334, reflecting a balance between a lower discount rate, slightly adjusted revenue growth assumptions, a modestly higher profit margin outlook, and a marginally higher future P/E multiple. What's in the News Board meeting scheduled for January 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended December 31, 2025.Aggiornamento narrativa • Feb 09
530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing
Analysts have revised their price target for Balaji Amines from ₹2,331 to ₹1,561, reflecting updated views on a lower assumed revenue growth rate, a slightly higher discount rate, a higher profit margin, and a reduced future P/E multiple. What's in the News Board meeting scheduled for Jan 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).Aggiornamento narrativa • Jan 25
530999: Richer Forward P/E Will Likely Support Returns Despite Thinner Margins
Analysts have raised their price target for Balaji Amines from ₹1,185 to ₹1,334, reflecting revised assumptions of higher revenue growth and a richer forward P/E multiple, partly offset by a lower profit margin outlook and a slightly higher discount rate. What's in the News Board meeting scheduled on Jan 29, 2026, to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).Aggiornamento narrativa • Jan 10
530999: Stable Margins And Upcoming Results Will Support Further Upside
Analysts have maintained their price target for Balaji Amines at ₹1,616.67, reflecting largely unchanged assumptions on the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for November 10, 2025, to consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2025 (company filing).Aggiornamento narrativa • Dec 25
530999 Will Likely See Slower Expansion Offset By Stronger Profit Margins
Analysts have reduced their fair value estimate for Balaji Amines to ₹1,185 from ₹1,598, citing expectations of slower revenue growth and a lower future P E multiple. This is partially offset by improved projected profit margins and a slightly higher discount rate.Aggiornamento narrativa • Dec 11
530999: Stable Margins And Growth Outlook Will Support Further Upside
Analysts have modestly lifted their price target on Balaji Amines to ₹1,616.67 per share, reflecting slightly higher assumed discount rates and steady long term growth and margin expectations that together support a marginally richer valuation multiple. What's in the News Board meeting scheduled on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).Aggiornamento narrativa • Nov 27
530999: Rising Profit Margins Will Drive Further Upside Despite Slower Sales
Analysts have revised their price target for Balaji Amines downward from ₹1,847 to ₹1,617. This change is due to expectations of slower revenue growth, even though profit margin projections have improved.Aggiornamento narrativa • Sep 05
New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential
With both the Future P/E and Discount Rate showing only marginal changes, analysts have effectively maintained their valuation outlook for Balaji Amines, resulting in an unchanged consensus price target of ₹1847. What's in the News Board meeting scheduled to consider and approve un-audited standalone and consolidated financial results for the quarter ended 30 June 2025.
Nuova narrativa • Feb 02
New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential
New plant expansions and strategic focus on high-margin products promise revenue growth and improved net margins through enhanced efficiency and diversification.Ripartizione dei ricavi e delle spese
Ripartizione dei ricavi e delle spese
Come Balaji Amines guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storico di utili e ricavi
| Data | Ricavi | Utili | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 30 Jun 26 | 15,226 | 2,041 | 896 | 0 |
| 31 Mar 26 | 14,250 | 1,672 | 842 | 0 |
| 31 Dec 25 | 13,829 | 1,441 | 813 | 0 |
| 30 Sep 25 | 13,643 | 1,458 | 816 | 0 |
| 30 Jun 25 | 13,707 | 1,522 | 815 | 0 |
| 31 Mar 25 | 13,971 | 1,575 | 802 | 0 |
| 31 Dec 24 | 14,583 | 1,855 | 828 | 0 |
| 30 Sep 24 | 15,289 | 2,017 | 848 | 0 |
| 30 Jun 24 | 15,626 | 1,954 | 848 | 0 |
| 31 Mar 24 | 16,415 | 2,049 | 833 | 0 |
| 31 Dec 23 | 16,990 | 1,842 | 761 | 0 |
| 30 Sep 23 | 19,019 | 1,974 | 751 | 0 |
| 30 Jun 23 | 21,489 | 2,553 | 771 | 0 |
| 31 Mar 23 | 23,554 | 3,255 | 855 | 0 |
| 31 Dec 22 | 26,652 | 3,868 | 1,050 | 0 |
| 30 Sep 22 | 26,451 | 4,138 | 1,093 | 0 |
| 30 Jun 22 | 25,433 | 4,010 | 1,077 | 0 |
| 31 Mar 22 | 23,229 | 3,684 | 969 | 0 |
| 31 Dec 21 | 19,598 | 3,442 | 896 | 0 |
| 30 Sep 21 | 17,844 | 3,296 | 850 | 0 |
| 30 Jun 21 | 15,411 | 2,956 | 809 | 0 |
| 31 Mar 21 | 13,133 | 2,382 | 735 | 0 |
| 31 Dec 20 | 11,592 | 1,845 | 477 | 0 |
| 30 Sep 20 | 9,946 | 1,329 | 429 | 0 |
| 30 Jun 20 | 9,395 | 1,186 | 392 | 0 |
| 31 Mar 20 | 9,395 | 1,048 | 557 | 0 |
| 31 Dec 19 | 9,095 | 1,000 | 328 | 0 |
| 30 Sep 19 | 9,214 | 1,029 | 304 | 0 |
| 30 Jun 19 | 9,319 | 1,036 | 312 | 0 |
| 31 Mar 19 | 9,468 | 1,175 | 332 | 0 |
| 31 Mar 18 | 8,644 | 1,132 | 296 | 0 |
| 31 Mar 17 | 6,730 | 824 | 266 | 0 |
| 31 Mar 16 | 6,446 | 576 | 233 | 0 |
Guadagni di qualità: 530999 ha guadagni di alta qualità.
Margine di profitto in crescita: Gli attuali margini di profitto netti di 530999 (13.4%) 530999 sono più alti rispetto allo scorso anno (11.1%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: Gli utili di 530999 sono diminuiti del 19.9% all'anno negli ultimi 5 anni.
Accelerare la crescita: La crescita degli utili di 530999 nell'ultimo anno ( 34.1% ) supera la media quinquennale ( -19.9% all'anno).
Guadagni vs Settore: La crescita degli utili 530999 nell'ultimo anno ( 34.1% ) ha superato la percentuale del settore Chemicals 20.8%.
Rendimento del capitale proprio
ROE elevato: Il Return on Equity ( 9.8% ) di 530999 è considerato basso.
Rendimento delle attività
Rendimento del capitale investito
Scoprire le aziende con forti performance passate
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/08/19 23:04 |
| Prezzo dell'azione a fine giornata | 2026/08/19 00:00 |
| Utili | 2026/06/30 |
| Utili annuali | 2026/03/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Balaji Amines Limited è coperta da 4 analisti. 2 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Nilesh Ghuge | HDFC Securities Limited |
| Jay Gandhi | HDFC Securities Limited |
| Keshav Lahoti | HDFC Securities Limited |